Nuveen International Dividend Growth Fund Class I (NUIIX)
Fund Assets | 4.97M |
Expense Ratio | 0.90% |
Min. Investment | $100,000 |
Turnover | n/a |
Dividend (ttm) | 1.20 |
Dividend Yield | 3.98% |
Dividend Growth | 54.52% |
Payout Frequency | Quarterly |
Ex-Dividend Date | Mar 31, 2025 |
Previous Close | 30.07 |
YTD Return | 7.87% |
1-Year Return | 6.22% |
5-Year Return | 59.50% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 41 |
Inception Date | Jun 11, 2012 |
About NUIIX
The Fund's investment strategy focuses on International with 0.9% total expense ratio. The minimum amount to invest in Nuveen Investment Trust II: Nuveen Santa Barbara International Dividend Growth Fund; Class I Shares is $100,000 on a standard taxable account. Nuveen Investment Trust II: Nuveen Santa Barbara International Dividend Growth Fund; Class I Shares seeks an attractive total return comprised of income from dividends and long-term capital appreciation. NUIIX invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in non-US dividend-paying equity securities, which include preferred securities.
Performance
NUIIX had a total return of 6.22% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.08%.
Top 10 Holdings
38.88% of assetsName | Symbol | Weight |
---|---|---|
SAP SE | SAP | 4.98% |
BAE Systems plc | BA | 4.70% |
Sanofi | SAN | 4.57% |
ITOCHU Corporation | 8001 | 4.29% |
Taiwan Semiconductor Manufacturing Company Limited | TSM | 3.88% |
Fixed Income Clearing Corp Repo | n/a | 3.37% |
TotalEnergies SE | TTE | 3.35% |
Macquarie Group Limited | MQG | 3.26% |
Hikma Pharmaceuticals PLC | HIK | 3.25% |
Unilever PLC | ULVR | 3.23% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Mar 31, 2025 | $0.1116 | Apr 1, 2025 |
Dec 30, 2024 | $0.0544 | Dec 31, 2024 |
Dec 16, 2024 | $0.5826 | Dec 17, 2024 |
Sep 30, 2024 | $0.1606 | Oct 1, 2024 |
Jun 28, 2024 | $0.2945 | Jul 1, 2024 |
Mar 28, 2024 | $0.1531 | Apr 1, 2024 |